Post by NUM Study Network

757 followers

๐—ก๐—จ๐—  ๐—ฆ๐˜๐˜‚๐—ฑ๐˜† ๐—ก๐—ฒ๐˜๐˜„๐—ผ๐—ฟ๐—ธ ๐—ถ๐—ป๐˜ƒ๐—ถ๐˜๐—ฒ๐—ฑ ๐—ฏ๐˜† ๐—ง๐— ๐—™ ๐—ฒ.๐—ฉ. ๐—ฎ๐—ป๐—ฑ ๐—ž๐—ž๐—ฆ๐—ก ๐Ÿ™ We were given the opportunity by TMF e. V. and KKS Netzwerk to participate in today's meeting of their work group โ€œClinical Trialsโ€(AG Klinische Studien), in order to present the #NUMStudyNetwork. ๐Ÿ‘‰ Our managing director Dr. Ramsia Geisler gave a talk on the mission, structure and work flows of the #NUMStudyNetwork and the Specialty Network Infectious Diseases (#SNID), and was joined to facilitate the follow-up discussion by Jรถrg Janne Vehreschild. The thematic session was complemented by Sebastian Klammt's input on the collaboration between the KKS-Netzwerk e. V. and the NUM Study Network, as well as by Sabine HanรŸ information on the #NUKLEUS project of Netzwerk Universitรคtsmedizin (NUM). ๐Ÿ’กThe programm also featured updates on legal issues concerning clinical trials (Sebastian Klammt), as well as reports from the work group โ€œEthics Commission" (Arbeitskreis Medizinischer Ethik-Kommissionen) (Georg Schmidt), the #KKSN (Sebastian Klammt) and the TMF e. V. ( Sebastian Claudius Semler). Many thanks ๐Ÿ™to TMF e.V. and KKSN for inviting us!๐Ÿค #NUMStudyNetwork #NUM #BMFTR #SNID Dr. Anna Finzel

Post content